37th Swiss Venture Day

Five start-ups will present at the next Swiss Venture Day on 24 May at ETH Zurich. Most of them are later stage companies presenting for the second or third time. They all have developed solutions to important problems ranging from radiological contraband to antibiotic resistance. But that’s not all. The solutions of the companies are also more cost-efficient than existing technologies. A very promising combination.

Arktis Radiation Detectors
The radiation detection technology the company has developed offers a new tool for screening cargo containers for illicit radiological contraband. The technology allows upgrading existing solutions to dramatically improve sensitivity and efficiency. The market is growing caused by legislature mandating 100% screening.

BioVersys
Antibiotic resistance is a rising problem for hospital acquired bacterial infections. BioVersys develops compounds that block antibiotic resistance and thus render approved antibiotics effective again. The resulting fixed combination drugs enter a market of high unmet medical need.

Biognosys
Biognosys has developed a solution to quantify proteins from a drop of blood. With a novel mass spectrometric technology we can record protein signals from 1000s of proteins in a single instrument run. This represents the key to personalized medicine and will enable to monitor individual protein levels for health monitoring and early detection of diseases.

Virometix
Vaccines are non-hazardous versions of pathogens today produced either in a nutrient solution or by genetically altered bacteria – until now, that is, because Virometix has created a broadly applicable technology platform for manufacturing vaccines chemically. Such a manufacturing process is not only simpler and more cost-efficient but also safer.

Gr3n
Chemical recycling of PET did not find an industrial implementation up to now because with the existing technology recycling plants had to treat more than 50,000 tons of PET per year, in order to reach the breakeven point. Such amount is hardly collectable in a single location. With its disruptive technology Gr3n reduces the breakeven point drastically.

Before the presentations the General Annual Meeting of CTI Invest will be held. In the afternoon the >>venture>> 2012 investor day will follow, where investors can see the early stage projects of the best 20 teams of the >>venture>> competition. In the evening the >>venture>> awards ceremony takes place at the same location.

More information and registration on the CTI Invest website.